Simplex Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-137
Closed -$19K 8379
2018
Q1
$19K Sell
137
-156
-53% -$144 ﹤0.01% 3448
2017
Q4
$52K Sell
293
-11
-4% -$18 ﹤0.01% 2423
2017
Q3
$35K Buy
304
+2
+0.7% +$5 ﹤0.01% 2643
2017
Q2
$24K Sell
302
-170
-36% -$510 ﹤0.01% 3151
2017
Q1
$41K Buy
472
+417
+758% +$1.65K ﹤0.01% 2568
2016
Q4
$14K Sell
55
-15
-21% -$35 ﹤0.01% 3445
2016
Q3
$16K Buy
70
+58
+483% +$219 ﹤0.01% 3230
2016
Q2
$17K Sell
12
-7
-37% -$32 ﹤0.01% 3075
2016
Q1
$42K Sell
19
-3
-14% -$39 ﹤0.01% 2123
2015
Q4
$27K Buy
22
+8
+57% +$191 ﹤0.01% 2464
2015
Q3
$20K Buy
14
+11
+367% +$377 ﹤0.01% 2829
2015
Q2
$6K Sell
3
-31
-91% -$1.85K ﹤0.01% 3618
2015
Q1
$6K Buy
34
+11
+48% +$682 ﹤0.01% 3451
2014
Q4
$23K Buy
+23
New +$1.16K ﹤0.01% 1956

Simplex Trading's OREX Position: Q3 2018 in Review

Simplex Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2018, closing a stake of 5,500 shares.

Simplex Trading first reported a position in OREX in Q4 2014 and held it in 12 quarters. The position peaked at $79K in Q4 2014. 1 fund tracked by Wall St. Rank holds OREX as of Q3 2018.

  • Simplex Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 5,500 Orexigen Therapeutics, Inc. shares in Q3 2018.
  • Simplex Trading first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • Simplex Trading's Orexigen Therapeutics, Inc. position peaked at $79K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.